As of Q4'25 (2025-12-31), RXRX reported an operating income of -108M USD, representing a significant improvement from the previous quarter's -172M USD. The year-over-year growth rate for this period stands at 41.05%, indicating a notable positive shift compared to prior quarters. Over the period from Q1'23 to Q4'25, RXRX's operating income exhibited a generally negative trend, with losses deepening through 2024 and peaking at -191M USD in Q1'25. However, the data shows a sharp recovery in Q4'25, both in absolute operating income and YoY growth, reversing the previous pattern of widening losses. This inflection suggests a potential turnaround in operational performance after a prolonged period of deterioration.